Respiratory exacerbations in indigenous children from two countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis

Chest

Volumn 146, Issue 3, 2014, Pages 762-774

  Redding, Gregory J ^a,b   Singleton, Rosalyn J ^c,d   Valery, Patricia C ^e   Williams, Hayley ^e   Grimwood, Keith ^f,g   Morris, Peter S ^e   Torzillo, Paul J ^h   McCallum, Gabrielle B ^e   Chikoyak, Lori ⁱ   Holman, Robert C ^j   Chang, Anne B ^e,k  

^a SEATTLE CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ALASKA NATIVE TRIBAL HEALTH CONSORTIUM   (United States)

^d NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^e MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

^h ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁱ Yukon Kuskokwim Health Corporation   (United States)

^j NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^k QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT;

ARTICLE; AUSTRALIA; BRONCHIECTASIS; CAREGIVER; CHILD; CHRONIC LUNG DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INDIGENOUS PEOPLE; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PARENT; PHYSICAL EXAMINATION; PNEUMONIA; PRESCHOOL CHILD; RECURRENT DISEASE; SCHOOL CHILD; UNITED STATES; CHRONIC DISEASE; COHORT ANALYSIS; COUGH; EPIDEMIOLOGY; ETHNOLOGY; LONGITUDINAL STUDY; LUNG DISEASES; POPULATION GROUP; PROSPECTIVE STUDY; RISK FACTOR; SUPPURATION;

ALASKA; AUSTRALIA; BRONCHIECTASIS; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; COHORT STUDIES; COUGH; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; LUNG DISEASES; MALE; POPULATION GROUPS; PROSPECTIVE STUDIES; RISK FACTORS; SUPPURATION;

EID: 84907186771     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-0126     Document Type: Article

References (28)

1. Barker AF, Bardana EJ Jr. Bronchiectasis: update of an orphan disease. Am Rev Respir Dis. 1988; 137 (4): 969-978.
2. Chang AB, Masel JP, Boyce NC, Wheaton G, Torzillo PJ. Non-CF bronchiectasis: clinical and HRCT evaluation. Pediatr Pulmonol. 2003; 35 (6): 477-483.
3. Fleshman JK, Wilson JF, Cohen JJ. Bronchiectasis in Alaska Native children. Arch Environ Health. 1968; 17 (4): 517-523.
4. Singleton R, Morris A, Redding G, et al. Bronchiectasis in Alaska Native children: causes and clinical courses. Pediatr Pulmonol. 2000; 29 (3): 182-187.
5. Edwards EA, Asher MI, Byrnes CA. Paediatric bronchiectasis in the twenty-fi rst century: experience of a tertiary children's hospital in New Zealand. J Paediatr Child Health. 2003; 39 (2): 111-117.
6. Chang AB, Grimwood K, Mulholland EK, Torzillo PJ; Working Group on Indigenous Paediatric Respiratory Health. Bronchiectasis in indigenous children in remote Australian communities. Med J Aust. 2002; 177 (4): 200-204.
7. Twiss J, Metcalfe R, Edwards E, Byrnes C. New Zealand national incidence of bronchiectasis "too high" for a developed country. Arch Dis Child. 2005; 90 (7): 737-740.
8. Redding GJ. Bronchiectasis in children. Pediatr Clin North Am. 2009; 56 (1): 157-171.
9. Roberts ME, Lowndes L, Milne DG, Wong CA. Socioeconomic deprivation, readmissions, mortality and acute exacerbations of bronchiectasis. Intern Med J. 2012; 42 (6): e129-e136.
10. Kapur N, Masters IB, Newcombe P, Chang AB. The burden of disease in pediatric non-cystic fibrosis bronchiectasis. Chest. 2012; 141 (4): 1018-1024.
11. Wong C, Jayaram L, Karalus N, et al. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial. Lancet. 2012; 380 (9842): 660-667.
12. Valery PC, Morris PS, Grimwood K, et al. Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial. BMC Pediatr. 2012; 12 (122): 122.
13. Singleton RJ, Valery PC, Morris P, et al. Indigenous children from three countries with non-cystic fibrosis chronic suppurative lung disease/bronchiectasis. Pediatr Pulmonol. 2014; 49 (2): 189-200.
14. Hare KM, Singleton RJ, Grimwood K, et al. Longitudinal nasopharyngeal carriage and antibiotic resistance of respiratory bacteria in indigenous Australian and Alaska native children with bronchiectasis. PLoS ONE. 2013; 8 (8): e70478.
15. Webb W, Muller N, Naidich D. Airway Diseases. High-Resolution CT of the Lung. Philadelphia, PA: Lippincott, Williams & Wilkins; 2001.
16. Eastham KM, Fall AJ, Mitchell L, Spencer DA. The need to redefi ne non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004; 59 (4): 324-327.
17. Byrnes CA, Vidmar S, Cheney JL, et al; ACFBAL Study Investigators. Prospective evaluation of respiratory exacerbations in children with cystic fibrosis from newborn screening to 5 years of age. Thorax. 2013; 68 (7): 643-651.
18. Chang AB, Redding GJ, Everard ML. Chronic wet cough: protracted bronchitis, chronic suppurative lung disease and bronchiectasis. Pediatr Pulmonol. 2008; 43 (6): 519-531.
19. Field CE. Bronchiectasis. Th ird report on a follow-up study of medical and surgical cases from childhood. Arch Dis Child. 1969; 44 (237): 551-561.
20. Landau LI, Phelan PD, Williams HE. Ventilatory mechanics in patients with bronchiectasis starting in childhood. Thorax. 1974; 29 (3): 304-312.
21. Edwards EA, Metcalfe R, Milne DG, Thompson J, Byrnes CA. Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships. Pediatr Pulmonol. 2003; 36 (2): 87-93.
22. Kapur N, Masters IB, Chang AB. Longitudinal growth and lung function in pediatric non-cystic fibrosis bronchiectasis: what influences lung function stability? Chest. 2010; 138 (1): 158-164.
23. Munro KA, Reed PW, Joyce H, et al. Do New Zealand children with noncystic fibrosis bronchiectasis show disease progression? Pediatr Pulmonol. 2011; 46 (2): 131-138.
24. Kim HY, Kwon JW, Seo J, et al. Bronchiectasis in children: 10-year experience at a single institution. Allergy Asthma Immunol Res. 2011; 3 (1): 39-45.
25. Bouyahia O, Essadem L, Matoussi N, et al. Etiology and outcome of bronchiectasis in children: a study of 41 patients. Tunis Med. 2008; 86 (11): 996-999.
26. Bastardo CM, Sonnappa S, Stanojevic S, et al. Non-cystic fibrosis bronchiectasis in childhood: longitudinal growth and lung function. Thorax. 2009; 64 (3): 246-251.
27. Haidopoulou K, Calder A, Jones A, Jaff e A, Sonnappa S. Bronchiectasis secondary to primary immunodefi ciency in children: longitudinal changes in structure and function. Pediatr Pulmonol. 2009; 44 (7): 669-675.
28. Kapur N, Masters IB, Chang AB. Exacerbations in noncystic fibrosis bronchiectasis: clinical features and investigations. Respir Med. 2009; 103 (11): 1681-1687.